Recombinant Vaccines Market Report

Global and China Recombinant Vaccines Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 14, 2022
  • PAGES：231
  • REPORT CODE：GMM1373843
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Recombinant vaccines are one of the most important tools in the medical industry today. These vaccines help prevent the spread of many infectious diseases, such as hepatitis B. In recent years, the growth of the market has been driven by a sharp increase in the incidence of infectious diseases, increased regulatory approvals, increased awareness of health care, and continued innovation in drug and vaccine development.

    This report elaborates on the current development of the Recombinant Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Green Cross Corporation

    • Sanofi S A

    • Pfizer Inc

    • GlaxoSmithKline Plc

    • Bharat Biotech

    • Novartis AG

    • Protein Science Corporation

    • Merck & Co, Inc

    • Bayer AG

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Subunit Recombinant Vaccines

    • Attenuated Recombinant Vaccines

    • Vector Recombinant Vaccines

    Application:

    • Hospitals & clinics

    • Pediatrics

    • Adults

    • Veterinary

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Recombinant Vaccines Industry Overview

      • 1.1.1 Recombinant Vaccines Market Scope and Market Segments

      • 1.1.2 Recombinant Vaccines Industry Characteristics

      • 1.1.3 Global and China Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Recombinant Vaccines Production Value and Growth Rate (2017-2028)

    • 1.2 Global Recombinant Vaccines Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Subunit Recombinant Vaccines

      • 1.2.2 Attenuated Recombinant Vaccines

      • 1.2.3 Vector Recombinant Vaccines

    • 1.3 Global Recombinant Vaccines Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals & clinics

      • 1.3.2 Pediatrics

      • 1.3.3 Adults

      • 1.3.4 Veterinary

      • 1.3.5 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Recombinant Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Recombinant Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Recombinant Vaccines Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Recombinant Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Recombinant Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Recombinant Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Recombinant Vaccines Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Recombinant Vaccines Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Recombinant Vaccines Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Recombinant Vaccines Industry Porter's Five Forces Model Analysis

      • 2.2.3 Recombinant Vaccines Industry PEST Analysis

    • 2.3 Recombinant Vaccines Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Recombinant Vaccines Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Recombinant Vaccines Industry

    Chapter 3 Global and China Recombinant Vaccines Market, by Manufacturer

    • 3.1 Global and China Recombinant Vaccines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Recombinant Vaccines Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Recombinant Vaccines Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Recombinant Vaccines Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Recombinant Vaccines Market Top 3 Players

    Chapter 4 Global and China Recombinant Vaccines Market, by Type (2017-2028)

    • 4.1 Recombinant Vaccines Market Trend, by Type

    • 4.2 Global Recombinant Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Recombinant Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Recombinant Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Recombinant Vaccines Price Trend, by Type (2017-2028)

    • 4.3 China Recombinant Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Recombinant Vaccines Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Recombinant Vaccines Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Recombinant Vaccines Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Recombinant Vaccines Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Recombinant Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Recombinant Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Recombinant Vaccines Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Recombinant Vaccines Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Recombinant Vaccines Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Recombinant Vaccines Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Recombinant Vaccines Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Recombinant Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Recombinant Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Recombinant Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Recombinant Vaccines Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Recombinant Vaccines Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Recombinant Vaccines Market Analysis

    • 7.1 North America Recombinant Vaccines Market, by Type

    • 7.2 North America Recombinant Vaccines Market, by Application

    • 7.3 North America Recombinant Vaccines Market Analysis and Forecast, by Country

      • 7.3.1 United States Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Recombinant Vaccines Market Analysis

    • 8.1 Europe Recombinant Vaccines Market, by Type

    • 8.2 Europe Recombinant Vaccines Market, by Application

    • 8.3 Europe Recombinant Vaccines Market Analysis and Forecast, by Country

      • 8.3.1 Germany Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Recombinant Vaccines Market Analysis

    • 9.1 APAC Recombinant Vaccines Market, by Type

    • 9.2 APAC Recombinant Vaccines Market, by Application

    • 9.3 APAC Recombinant Vaccines Market Analysis and Forecast, by Country

      • 9.3.1 China Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Recombinant Vaccines Market Analysis

    • 10.1 Latin America, Middle East and Africa Recombinant Vaccines Market, by Type

    • 10.2 Latin America, Middle East and Africa Recombinant Vaccines Market, by Application

    • 10.3 Latin America, Middle East and Africa Recombinant Vaccines Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Recombinant Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Recombinant Vaccines Company Profiles

      • 11.1 Green Cross Corporation

        • 11.1.1 Green Cross Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Green Cross Corporation Recombinant Vaccines Product Profiles, Application and Specification

        • 11.1.3 Green Cross Corporation Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Sanofi S A

        • 11.2.1 Sanofi S A Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Sanofi S A Recombinant Vaccines Product Profiles, Application and Specification

        • 11.2.3 Sanofi S A Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Pfizer Inc

        • 11.3.1 Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Pfizer Inc Recombinant Vaccines Product Profiles, Application and Specification

        • 11.3.3 Pfizer Inc Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 GlaxoSmithKline Plc

        • 11.4.1 GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 GlaxoSmithKline Plc Recombinant Vaccines Product Profiles, Application and Specification

        • 11.4.3 GlaxoSmithKline Plc Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Bharat Biotech

        • 11.5.1 Bharat Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Bharat Biotech Recombinant Vaccines Product Profiles, Application and Specification

        • 11.5.3 Bharat Biotech Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Novartis AG

        • 11.6.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Novartis AG Recombinant Vaccines Product Profiles, Application and Specification

        • 11.6.3 Novartis AG Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Protein Science Corporation

        • 11.7.1 Protein Science Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Protein Science Corporation Recombinant Vaccines Product Profiles, Application and Specification

        • 11.7.3 Protein Science Corporation Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Merck & Co, Inc

        • 11.8.1 Merck & Co, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Merck & Co, Inc Recombinant Vaccines Product Profiles, Application and Specification

        • 11.8.3 Merck & Co, Inc Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Bayer AG

        • 11.9.1 Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Bayer AG Recombinant Vaccines Product Profiles, Application and Specification

        • 11.9.3 Bayer AG Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Recombinant Vaccines Industry Investment Prospect and Risk Assessment

    • 12.1 Recombinant Vaccines Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Recombinant Vaccines Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Global Recombinant Vaccines Production Value and Growth Rate (2017-2028)

    • Figure China Recombinant Vaccines Production Value and Growth Rate (2017-2028)

    • Figure Global Recombinant Vaccines Market Size and Growth Rate of Subunit Recombinant Vaccines (2017-2028)

    • Figure Global Recombinant Vaccines Market Size and Growth Rate of Attenuated Recombinant Vaccines (2017-2028)

    • Figure Global Recombinant Vaccines Market Size and Growth Rate of Vector Recombinant Vaccines (2017-2028)

    • Figure Global Recombinant Vaccines Market Size and Growth Rate of Hospitals & clinics (2017-2028)

    • Figure Global Recombinant Vaccines Market Size and Growth Rate of Pediatrics (2017-2028)

    • Figure Global Recombinant Vaccines Market Size and Growth Rate of Adults (2017-2028)

    • Figure Global Recombinant Vaccines Market Size and Growth Rate of Veterinary (2017-2028)

    • Figure Global Recombinant Vaccines Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Recombinant Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Recombinant Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Recombinant Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Recombinant Vaccines Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Recombinant Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Recombinant Vaccines Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Recombinant Vaccines Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Recombinant Vaccines Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Recombinant Vaccines Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Recombinant Vaccines Market Share, by Manufacturer in 2021

    • Figure Global and China Recombinant Vaccines Market Share, by Manufacturer in 2022

    • Table Global Recombinant Vaccines Sales Volume, by Type (2017-2028)

    • Table Global Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Global Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Global Recombinant Vaccines Sales Value, by Type (2017-2028)

    • Table Global Recombinant Vaccines Sales Value Share, by Type (2017-2028)

    • Figure Global Recombinant Vaccines Price Trend, by Type (2017-2028)

    • Table China Recombinant Vaccines Sales Volume, by Type (2017-2028)

    • Table China Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure China Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Table China Recombinant Vaccines Sales Value, by Type (2017-2028)

    • Table China Recombinant Vaccines Sales Value Share, by Type (2017-2028)

    • Figure China Recombinant Vaccines Price Trend, by Type (2017-2028)

    • Table Global Recombinant Vaccines Sales Volume, by Application (2017-2028)

    • Table Global Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Global Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Table Global Recombinant Vaccines Sales Value, by Application (2017-2028)

    • Table Global Recombinant Vaccines Sales Value Share, by Application (2017-2028)

    • Figure Global Recombinant Vaccines Sales Value Share, by Application (2017-2028)

    • Table China Recombinant Vaccines Sales Volume, by Application (2017-2028)

    • Table China Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Table China Recombinant Vaccines Sales Value, by Application (2017-2028)

    • Table China Recombinant Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Recombinant Vaccines Sales Value Share, by Application (2017-2028)

    • Figure China Recombinant Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure North America Recombinant Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Recombinant Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Recombinant Vaccines Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Recombinant Vaccines Production, Import, Consumption and Export (2017-2022)

    • Table North America Recombinant Vaccines Sales Volume, by Type (2017-2028)

    • Table North America Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure North America Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Table North America Recombinant Vaccines Sales Volume, by Application (2017-2028)

    • Table North America Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure North America Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure United States Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure United States Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Canada Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Europe Recombinant Vaccines Sales Volume, by Type (2017-2028)

    • Table Europe Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Europe Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Europe Recombinant Vaccines Sales Volume, by Application (2017-2028)

    • Table Europe Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Europe Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Germany Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure UK Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure UK Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure France Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure France Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Italy Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Spain Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Poland Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Russia Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Table APAC Recombinant Vaccines Sales Volume, by Type (2017-2028)

    • Table APAC Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure APAC Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Table APAC Recombinant Vaccines Sales Volume, by Application (2017-2028)

    • Table APAC Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure APAC Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure China Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure China Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Japan Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure India Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure India Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Vaccines Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Recombinant Vaccines Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Vaccines Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Recombinant Vaccines Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Recombinant Vaccines Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Recombinant Vaccines Sales Value and Growth Rate (2017-2028)

    • Table Green Cross Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Green Cross Corporation Product Profiles, Application and Specification

    • Table Green Cross Corporation Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi S A Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi S A Product Profiles, Application and Specification

    • Table Sanofi S A Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Inc Product Profiles, Application and Specification

    • Table Pfizer Inc Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Plc Product Profiles, Application and Specification

    • Table GlaxoSmithKline Plc Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bharat Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bharat Biotech Product Profiles, Application and Specification

    • Table Bharat Biotech Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Protein Science Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Protein Science Corporation Product Profiles, Application and Specification

    • Table Protein Science Corporation Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck & Co, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck & Co, Inc Product Profiles, Application and Specification

    • Table Merck & Co, Inc Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer AG Product Profiles, Application and Specification

    • Table Bayer AG Recombinant Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US